(Q37084277)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273722%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

review article

1 reference

title

The pharmacoeconomics of acne treatment: where are we heading? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273722%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273722%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Marc J Inglese

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273722%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Alan B Fleischer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273722%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Rajesh Balkrishnan

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273722%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273722%20AND%20SRC:MED&resulttype=core&format=json

Journal of Dermatological Treatment

2 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273722%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273722%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273722%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

27-37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273722%20AND%20SRC:MED&resulttype=core&format=json

The evaluation and management of acne: economic considerations

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Managing acne in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Use of pharmacoeconomics in prescribing research. Part 1: costs--moving beyond the acquisition price for drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Assessing the economic impact of adverse drug effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Economics notes: handling uncertainty in economic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian Pharmaceutical Benefits Scheme

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Valuing health states: a comparison of methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Development and validation of a grading system for the quality of cost-effectiveness studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Isotretinoin: cost-benefit study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

How cost-effective is oral isotretinoin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Oral isotretinoin treatment policy. Do we all agree?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Use of isotretinoin (Accutane) in the United States: rapid increase from 1992 through 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

The psychosocial impact of acne: patients' perceptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Effect of isotretinoin on the quality of life of patients with acne.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Cumulative irritancy comparison of adapalene gel 0.1% versus other retinoid products when applied in combination with topical antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Physicians underutilize topical retinoids in the management of acne vulgaris: analysis of U.S. National Practice Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Management of acne: a report from a Global Alliance to Improve Outcomes in Acne.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

The effectiveness of acne treatment: an assessment by patients of the outcome of therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Health outcome measures used in cost-effectiveness studies: a review of original articles published between 1986 and 1996.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Understanding quality-adjusted life years and their application to pharmacoeconomic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Responsiveness of the Dermatology-specific Quality of Life (DSQL) instrument to treatment for acne vulgaris in a placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Bacterial resistance in acne.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Antibiotic-resistant acne: lessons from Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Does oral isotretinoin prevent Propionibacterium acnes resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Topical treatment in acne: current status and future aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Treatment of acne in the fee-for-service and managed care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

Balancing the cost and value of medications: the dilemma facing clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09546630701729895

10.1080/09546630701729895

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273722%20AND%20SRC:MED&resulttype=core&format=json

release_sb7ufegrknfiromjzqh4une5he

2 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sb7ufegrknfiromjzqh4une5he

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference